PARTICIPATION AGREEMENTParticipation Agreement • August 24th, 2007 • BG Medicine, Inc. • Services-medical laboratories • New York
Contract Type FiledAugust 24th, 2007 Company Industry JurisdictionThis Participation Agreement (this “Agreement”) is entered into as of the 22nd day of_December, 2006 (the “Effective Date”) by and between BG Medicine, Inc., a corporation having offices at 610 N. Lincoln Street, Waltham, Massachusetts 02451 (“BGM”) and Philips Medical Systems Nederland B.V. a company having offices at Veenpluis 4-6, 5684 PC Best, the Netherlands (“Philips” and “Participant”); each of Participant and BGM are sometimes referred to individually as a “Party” and collectively as the “Parties”).
PRODUCT LICENSE AND COLLABORATION AGREEMENTProduct License and Collaboration Agreement • August 24th, 2007 • BG Medicine, Inc. • Services-medical laboratories
Contract Type FiledAugust 24th, 2007 Company IndustryThis Product License and Collaboration Agreement (this “Agreement”) is made and entered into as of this 4 day of May, 2007 (the “Effective Date”), by and between (i) BG Medicine, Inc., a Delaware corporation (“BGM”), (ii) ACS Biomarker B.V. i.o. (“ACSB”), a corporation to be established by the University of Maastricht (the “University”), BioMedbooster B.V., a corporation organized under the laws of The Netherlands (“BioMedbooster”), Yigal Pinto, Mat Daemen, Tilman Hackeng and Marcel Kannekens, and (iii) solely for purposes of Section 3.04 hereof, the University and BioMedbooster.
PARTICIPATION AGREEMENTParticipation Agreement • August 24th, 2007 • BG Medicine, Inc. • Services-medical laboratories • New York
Contract Type FiledAugust 24th, 2007 Company Industry JurisdictionThis Participation Agreement (this “Agreement”) is entered into as of the 24th day of November, 2006 (the “Effective Date”) by and between BG Medicine, Inc., a corporation having offices at 610 N. Lincoln Street, Waltham, Massachusetts 02451 (“BGM”) and AstraZeneca AB., having offices in Södertälje SE-151 85, Sweden (“Participant”; each of Participant and BGM are sometimes referred to individually as a “Party” and collectively as the “Parties”).
RESTATEMENT AND AMENDMENT OF STRATEGIC RELATIONSHIP AGREEMENTStrategic Relationship Agreement • August 24th, 2007 • BG Medicine, Inc. • Services-medical laboratories
Contract Type FiledAugust 24th, 2007 Company Industry
PARTICIPATION AGREEMENTParticipation Agreement • August 24th, 2007 • BG Medicine, Inc. • Services-medical laboratories • New York
Contract Type FiledAugust 24th, 2007 Company Industry JurisdictionThis Participation Agreement (this “Agreement”) is entered into as of the 28th day of July, 2006 (the “Effective Date”) by and between BG Medicine, Inc., a corporation having offices at 610 N. Lincoln Street, Waltham, Massachusetts 02451 (“BGM”) and Merck & Co., Inc., having offices at One Merck Drive, Whitehouse Station, NJ 08889 (“Participant” ; each of Participant and BGM are sometimes referred to individually as a “Party” and collectively as the “Parties”).
STRATEGIC AGREEMENTStrategic Agreement • August 24th, 2007 • BG Medicine, Inc. • Services-medical laboratories • Florida
Contract Type FiledAugust 24th, 2007 Company Industry JurisdictionThis Strategic Agreement (“Agreement”) is made and entered into effective as of the 25 day of May, 2007 (“Effective Date”) by and between HUMANA INC. (“Humana”), a Delaware corporation, and BG MEDICINE, INC. (“BGM”), a Delaware corporation. Humana and BGM may be individually referred to herein to as a “Party” and collectively as the “Parties.”